Xeris Cushing’s syndrome drug Recorlev bags US approval by Editor | Jan 4, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0 USA – According to a press release by Xeris, the FDA has approved the steroidogenesis... Read More